Rezolute Provides Update on FDA Review of its Phase 3 sunRIZE Study Results in Congenital Hyperinsulinism Life Science Investing
Journey Medical Corporation to Participate in September 2026 Investor Conferences Life Science Investing
Gilead Opens State-of-the-Art Research Center to Advance the Next Generation of Medicines Life Science Investing
Johnson & Johnson spotlights new neuropsychiatry data across bipolar mania, depression and schizophrenia at Psych Congress 2026 Pharmaceutical Investing
BriaCell's Pivotal Phase 3 Metastatic Breast Cancer Study Expands to Leading Cancer Center Pharmaceutical Investing
NovaBridge Appoints Martin Dewhurst to Board of Directors as an Independent Director Life Science Investing
Bristol Myers Squibb Announces Positive Topline Results from Registrational Phase 2 QUINTESSENTIAL Trial of the Potential First-in-Class GPRC5D-Directed CAR T Cell Therapy, Arlocabtagene Autoleucel ... Life Science Investing
AbbVie Announces Positive Topline Results from the Phase 3 CERVINO Trial Showing Etentamig Significantly Improved Response Rate and Progression-Free Survival in Patients with Relapsed/Refractory Multiple Myeloma Pharmaceutical Investing
Rural Pharmacies Identify Thousands of Patients at Risk of Stroke, Heart Disease, Pilot Program Finds Life Science Investing
